Yiheng Capital Management’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.99M | Hold |
500,261
| – | – | 0.63% | 10 |
|
|
2025
Q1 | $6.74M | Sell |
500,261
-250,000
| -33% | -$3.37M | 0.63% | 9 |
|
|
2024
Q4 | $14.4M | Sell |
750,261
-97,630
| -12% | -$1.87M | 0.55% | 10 |
|
|
2024
Q3 | $19.3M | Sell |
847,891
-100,239
| -11% | -$2.28M | 0.99% | 9 |
|
|
2024
Q2 | $12.3M | Hold |
948,130
| – | – | 0.99% | 12 |
|
|
2024
Q1 | $16.6M | Sell |
948,130
-280,404
| -23% | -$4.91M | 0.92% | 12 |
|
|
2023
Q4 | $26.8M | Hold |
1,228,534
| – | – | 1.54% | 9 |
|
|
2023
Q3 | $18.8M | Hold |
1,228,534
| – | – | 0.96% | 14 |
|
|
2023
Q2 | $29.2M | Hold |
1,228,534
| – | – | 1.58% | 14 |
|
|
2023
Q1 | $31.3M | Buy |
1,228,534
+265,278
| +28% | +$6.75M | 1.24% | 13 |
|
|
2022
Q4 | $28.1M | Buy |
963,256
+590,205
| +158% | +$17.2M | 1.25% | 14 |
|
|
2022
Q3 | $7.65M | Buy |
+373,051
| New | +$7.65M | 0.47% | 19 |
|